Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1975 of 3546 entries
View as:

An Observational Study For Ambrisentan

Phase: N/A Priority: Normal
NCT ID: NCT00679224 Org: User:
Start: 06/30/08 End: 07/31/13 Due: 07/31/14

A Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVE

Phase: N/A Priority: Normal
NCT ID: NCT03312907 Org: User:
Start: 03/01/18 End: 07/07/21 Due: 07/07/22

A First Time in Human Study Exploring Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2618960 in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis (RRMS)

Phase: N/A Priority: Normal
NCT ID: NCT01808482 Org: User:
Start: 03/13/13 End: 08/06/13 Due: 08/06/14

Immunogenicity & Safety Study of Fluviral® (2010 - 2011 Season) in Adults Aged 18 to 60 Years and Over 60 Years

Phase: N/A Priority: Normal
NCT ID: NCT01153685 Org: User:
Start: 07/09/10 End: 07/31/10 Due: 07/31/11

A Study To Investigate The Antidepressant Effect Of Lamotrigine In Patients With Bipolar Disorder Using Lithium

Phase: N/A Priority: Normal
NCT ID: NCT00224510 Org: User:
Start: 08/31/02 End: 09/30/06 Due: 09/30/07

Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use

Phase: N/A Priority: Normal
NCT ID: NCT02794480 Org: User:
Start: 08/22/16 End: 12/15/16 Due: 12/15/17

Fluticasone Propionate-salmeterol Combination Adherence in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01381471 Org: User:
Start: 08/31/09 End: 05/31/10 Due: 05/31/11

Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1)

Phase: N/A Priority: Normal
NCT ID: NCT02723955 Org: User:
Start: 06/23/16 End: 07/05/23 Due: 07/05/24

A Study to Determine the Effect of Sumatriptan and Naproxen Sodium Combination Tablet, Sumatriptan Tablet, and Naproxen Sodium Tablet on Blood Pressure When Treating Migraine Headaches That Occur During a 6-month Period

Phase: N/A Priority: Normal
NCT ID: NCT00792636 Org: User:
Start: 11/30/08 End: 11/30/09 Due: 11/30/10

Single Oral Dose Study of Atovaquone/Proguanil Hydrochloride Combination Tablets and Atovaquone Suspension

Phase: N/A Priority: Normal
NCT ID: NCT01858831 Org: User:
Start: 04/30/12 End: 05/31/12 Due: 05/31/13

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine 2830930A Administered in Toddlers

Phase: N/A Priority: Normal
NCT ID: NCT01485406 Org: User:
Start: 12/12/11 End: 03/15/12 Due: 03/15/13

A Study to Determine the Excretion Balance and Pharmacokinetics of 14C-GSK573719

Phase: N/A Priority: Normal
NCT ID: NCT01362257 Org: User:
Start: 04/29/11 End: 06/22/11 Due: 06/22/12

Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry

Phase: N/A Priority: Normal
NCT ID: NCT01498653 Org: User:
Start: 01/31/12 End: 02/28/13 Due: 02/28/14

Bioequivalence Study of Cephalexin Suspension 250

Phase: N/A Priority: Normal
NCT ID: NCT01767571 Org: User:
Start: 01/30/11 End: 02/08/11 Due: 02/08/12

Combination Study Of SB-485232 (Interleukin 18) And Doxil For Advanced Stage Epithelial Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00659178 Org: User:
Start: 06/18/08 End: 02/18/11 Due: 02/18/12

Endotoxin Challenge Study For Healthy Men and Women

Phase: N/A Priority: Normal
NCT ID: NCT00515268 Org: User:
Start: 09/27/07 End: 04/23/08 Due: 04/23/09

An Investigation of the Pharmacokinetics of GSK961081 and Fluticasone Propionate in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01449799 Org: User:
Start: 07/13/11 End: 09/21/11 Due: 09/21/12

The Long-term Antibody Persistence of GSK Biologicals' Meningococcal Vaccine GSK134612 in Healthy Adolescents/Adults

Phase: N/A Priority: Normal
NCT ID: NCT00715910 Org: User:
Start: 07/31/08 End: 10/31/13 Due: 10/31/14

ALTARGO(Retapamulin) PMS(Post-marketing Surveillance)

Phase: N/A Priority: Normal
NCT ID: NCT01445600 Org: User:
Start: 11/30/12 End: 08/31/15 Due: 08/31/16

An Exercise Endurance Study to Evaluate the Effects of Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients With a Dual Bronchodilator: GSK573719/GW642444. Study A

Phase: N/A Priority: Normal
NCT ID: NCT01328444 Org: User:
Start: 03/01/11 End: 06/14/12 Due: 06/14/13

An Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01362296 Org: User:
Start: 09/30/11 End: 09/30/13 Due: 09/30/14

An Evaluation of the Pharmacokinetics of an Oral Contraceptive (Brevicon) When Co-administered With Albiglutide .

Phase: N/A Priority: Normal
NCT ID: NCT01077505 Org: User:
Start: 03/15/10 End: 11/24/10 Due: 11/24/11

Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin Hydrochloride (HCL) Combination Capsule in Fasted State

Phase: N/A Priority: Normal
NCT ID: NCT02052713 Org: User:
Start: 02/19/14 End: 12/29/14 Due: 12/29/15

Drug Interaction Assessment of GSK3882347 in Healthy Participants Aged 18 to 65 Years

Phase: N/A Priority: Normal
NCT ID: NCT05760261 Org: User:
Start: 04/11/23 End: 08/20/24 Due: 08/20/25

Bioequivalence of RYTHMOL SR® Manufactured at Two Different Sites

Phase: N/A Priority: Normal
NCT ID: NCT01956487 Org: User:
Start: 04/11/12 End: 06/27/12 Due: 06/27/13